Printer Friendly

JONES MEDICAL REPORTS SECOND QUARTER EARNINGS PER SHARE DOUBLED TO 18 CENTS, NET INCOME UP 97 PERCENT AND SALES UP 107 PERCENT

 ST. LOUIS, July 29 /PRNewswire/ -- Jones Medical Industries, Inc. (NASDAQ: JMED) today reported record results for the second quarter and six months ending June 30, 1993.
 Sales for the 1993 second quarter were up 107 percent to $12,288,000, operating income up 127 percent to $2,691,000, net income up 97 percent to $1,672,000 and earnings per share up 100 percent to $.18 on 9,540,000 average share outstanding. The comparative 1992 second quarter results were $5,945,000 sales, $1,186,000 operating income, $847,000 net income and earnings per share of $.09 on 9,454,000 average shares outstanding.
 Sales for the first six months of 1993 were up 62 percent to $19,063,000, operating income up 70 percent to $4,325,000, net income up 55 percent to $2,939,000 and earnings per share up 53 percent to $.29 on 9,520,000 shares outstanding. An additional $.02 per share earnings resulted during the first quarter from a one time accounting change. The comparative 1992 six month results were $11,751,000 sales, $2,546,000 operating income, $1,757,000 net income and earnings per share of $.19 on 9,466,000 average shares outstanding.
 Dennis M. Jones, chairman and CEO, in commenting on the JMED's second quarter results said, "The tremendously favorable impact of our two recent acquisitions was quite evident during this quarter. Bronson Pharmaceuticals contributed $3,800,000 in sales, and the Derma System Products contributed $500,000. Additionally, Thrombinar sales exceeded $3,000,000 compared to $1,800,000 for the same quarter a year ago due to the Company's ability to capitalize on a temporary outage of product by its principle competitor. All of these factors, added to our previously established base, culminated in an outstanding new level of quarterly sales for both of our business segments with Nutritional Product sales of $6.4 million and Pharmaceutical Product sales of $5.9 million. Going forward, we hope to continue triple digit growth in both sales and profits, for the next several quarters."
 JONES MEDICAL INDUSTRIES, INC.
 Second Quarter Ended June 30: 1993 1992
 Sales $12,288,000 $ 5,945,000
 Net Income $ 1,672,000 $ 847,000
 Per Share Net Income $ .18 $ .09
 Average Shares Outstanding 9,540,000 9,454,000
 Six Months Ended June 30: 1993 1992
 Sales $19,063,000 $11,751,000
 Net Income Before Accounting
 Change $ 2,732,000 $ 1,757,000
 Cumulative Effect Of Accounting
 Change $ 207,000 $ --
 Net Income $ 2,939,000 $ 1,757,000
 Average Shares Outstanding 9,520,000 9,466,000
 Per Share Earnings Before
 Accounting Change $ .29 $ .19
 Per Share From Accounting Change .02 --
 Per Share Net Income $ .31 $ .19
 -0- 7/29/93
 /CONTACT: Investor Relations of Jones Medical Industries, Inc., 314-432-7557/
 (JMED)


CO: Jones Medical Industries, Inc. ST: Missouri IN: MTC SU: ERN

MG -- NY060 -- 7226 07/29/93 13:09 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 29, 1993
Words:492
Previous Article:SKYTEL AND REUTERS TO PROVIDE WIRELESS NEWS HEADLINES; SUBSCRIBERS TO GET FREE NEWS UPDATES
Next Article:MEDIA GENERAL DECLARES DIVIDEND
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters